US$ 20.75
fda warning letter semaglutide october 2025 A company called Nomida has received an for offering for sale injectable weight-loss treatments. None of their offerings are FDA-approved. Nomida is allegedly selling unapproved and Tirzepatide "kits" FDA issued 25 warning letters
Description
Choi IY, Lee JS, Kim JK, et al
Ozempic (Semaglutide) FDA Approval History-Drugs

Natural GLP-1 gets broken down rapidly by an enzyme called DPP-4, usually within minutes
Brand claims - including support-availability, flat-pricing, and provider-review-time claims - are not independently verified

Eating too little is a common and underappreciated problem for GLP-1 users
Wegovy is more expensive than Ozempic, but less expensive than it would be if you were buying it in the US and some European countries, noted Dr
